David Cooper

David Cooper has worked in the medical field since 2002, beginning with a role as Medical Strategy Director at Quintiles. David then moved to Medsn in 2004 as VP, Medical Strategy and Content, followed by Senior Director, Medical Affairs at Novo Nordisk Inc. in 2005. In 2019, they took on the role of Vice President, Clinical Development, CNS at uniQure, and most recently they have been Chief Medical Officer at AviadoBio since 2022.

David Cooper has a long educational history. David earned a BA in Chemistry from Cornell University between 1982 and 1986. David then went on to earn an MD in Medicine from Cornell University between 1985 and 1989. Finally, they earned an MBA from Cornell Johnson Graduate School of Management from 2000 to 2001.